SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Jim B who wrote (1390)6/19/1998 11:04:00 AM
From: macker  Read Replies (2) | Respond to of 5402
 
i dont believe it would be tens of dollars on a buyout, i think it would be more in line with somatogen style numbers of 12-15. somatogen was bought out at 9 with another possibility of 3 dollars per share based on future revs produced. it was confusing but i think that is how it worked, do you know Andrew?

macker



To: Jim B who wrote (1390)6/19/1998 11:05:00 AM
From: FatMatty  Respond to of 5402
 
Great posts this morning folks...let's keep up the good words and research. I pulled some articles off simple Yahoo searches yesterday on 'Artificial Blood'. Others that want some simple background reading can easily do the same.

Matty


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News